Supernus Pharmaceuticals (SUPN) Revenue Growth (5y) (2016 - 2025)
Supernus Pharmaceuticals (SUPN) Revenue Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.20 Bn | 21.05 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.58 Bn | 12.15 Bn | 785.00 Mn |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.07% |
| Sep 30, 2025 | 4.37% |
| Mar 31, 2025 | 9.55% |
| Dec 31, 2024 | 11.64% |
| Sep 30, 2024 | 11.46% |
| Jun 30, 2024 | 9.96% |
| Mar 31, 2024 | 10.94% |
| Dec 31, 2023 | 7.22% |
| Sep 30, 2023 | 8.36% |
| Jun 30, 2023 | 6.37% |
| Mar 31, 2023 | 11.20% |
| Dec 31, 2022 | 13.60% |
| Sep 30, 2022 | 17.14% |
| Jun 30, 2022 | 17.53% |
| Mar 31, 2022 | 21.51% |
| Dec 31, 2021 | 20.59% |
| Sep 30, 2021 | 21.18% |
| Jun 30, 2021 | 22.31% |
| Mar 31, 2021 | 24.26% |
| Dec 31, 2020 | 26.86% |